(Q36989654)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Exposure to chemotherapeutic agents and the risk of a second breast cancer: preliminary findings (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

P L Horn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

W D Thompson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

publication date

1 May 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

Yale Journal of Biology and Medicine

19 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

223-231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

Dose-response effect of adjuvant chemotherapy in breast cancer

19 September 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2590453

Factors associated with the risk of second primary breast cancer: an analysis of data from the Connecticut Tumor Registry

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2590453

Discussion: Some comments on the potential carcinogenicity of the clinically useful antitumor agents

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2590453

Second neoplasms after adjuvant chemotherapy for operable breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2590453

Additive, multiplicative, and other models for disease risks

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2590453

Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience

27 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3176526

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tamoxifen and contralateral breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3176526

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Secondary neoplasms in patients treated for cancer: etiology and perspective

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3176526

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3176526%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference